Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis (Q71812809)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933780%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933780%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

main subject

fluticasone propionate

1 reference

Weido AJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933780%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Reece LM

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933780%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Alam R

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933780%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Cook CK

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933780%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sim TC

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933780%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 November 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933780%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933780%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933780%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933780%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

407-415

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933780%20AND%20SRC:MED&resulttype=core&format=json

Do cytokines play a role in leukocyte recruitment and activation in the lungs?

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Development of a new technique for recovery of cytokines from inflammatory sites in situ

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

CC chemokines in allergic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Macrophage inflammatory protein-1 alpha activates basophils and mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Activation of guinea pig lymphocytes and mast cells by grain-dust extract

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Effect of topical corticosteroids on the recovery of histamine releasing factors in nasal washings of patients with allergic rhinitis. A double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Mode of action of a topical steroid on immediate phase reaction after antigen challenge and nonspecific nasal hyperreactivity in nasal allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Topical glucocorticoids inhibit activation by allergen in the upper respiratory tract.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Biological and clinical aspects of interleukin 6.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Neutrophil attractant/activation protein-1 (NAP-1) causes human basophil histamine release

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Interleukin-8 is a chemo-attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Monocyte chemotactic protein 1 is a potent activator of human basophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Glucocorticoid inhibition of RANTES expression in human lung epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963340-6

7 January 2021

10.1016/S1081-1206(10)63340-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933780%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference